Posts
October 10 2014
Cytori Therapeutics, Inc. announced the closing of their Registered Direct offering in the amount of $13,500,000. EG&S acted as counsel to the Investor.
October 06 2014
DT Asia Investments Limited announced the completion of their IPO in the amount of $60,000,000. EG&S acted as counsel to DT Asia.
September 29 2014
Lpath, Inc. announced the closing of its previously announced $12.5 million registered direct offering. Lpath sold registered shares of common stock and warrants to purchase unregistered shares of common stock in a registered direct offering. EG&S acted as counsel to the placement agent.
September 24 2014
Baxano Surgical, Inc. announced the closing of their Registered Direct offering in the amount of $1,384,801. EG&S acted as counsel to the Investor.
September 23 2014
Advanced Plasma Therapies, Inc., a privately held, development-stage biotechnology company, closed a private common stock financing of $25 million with a single institutional investor. EG&S acted as counsel to Advanced Plasma Therapies.
September 23 2014
LabStyle Innovations Corp. (OTCQB:DRIO) announced the closing of a $4.2 million private placement consisting of preferred stock and warrants. EG&S acted as counsel to LabStyle.
September 22 2014
Hennessy Capital Acquisition Corp. announced the agreement to acquire Blue Bird. EG&S acted as co-counsel to Hennessy with Sidley Austin LLP.
September 11 2014
Douglas S. Ellenoff, a member of the Firm, will receive the “Crowdfunding Visionary Award” at the 3rd Annual Global Crowdfunding Convention and Bootcamp this October in Las Vegas.